Atlas Trials

Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms

Clinical trial NCT04407507 · COMPLETED

Trial details

NCT number
NCT04407507
Sponsor
Investigacion Biomedica para el Desarrollo de Farmacos S.A. de C.V.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2020-07-01
Primary completion
2021-01-29
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.